期刊： EXPERT REVIEW OF VACCINES, 2021; 20 (7)
Background: Although the inactivated SARS-CoV-2 vaccine (CoronaVac) has undergone preclinical tests and clinical trials evaluating its efficacy and sa......
期刊： EXPERT REVIEW OF VACCINES, 2021; 20 (6)
Introduction: Sabin strain inactivated poliovirus vaccine (sIPV) developed by Sinovac Biotech Co., Ltd., has shown good safety and immunogenicity agai......
期刊： EXPERT REVIEW OF VACCINES, 2021; 20 (9)
Background Vaccination uptake of influenza vaccine, 23-valent pneumococcal polysaccharide vaccine (PPV23) and herpes zoster vaccine (HZV) remains low ......
期刊： EXPERT REVIEW OF VACCINES, 2021; 20 (4)
Background: Rotavirus (RV), which causes RV-associated gastroenteritis (RVGE), has accounted for considerable morbidity. We aimed to assess the effect......
期刊： EXPERT REVIEW OF VACCINES, 2021; 20 (5)
Objectives Seasonal influenza vaccine coverage remains low in China due to possible influenza vaccine hesitancy (IVH) and practical issues. We sought ......
期刊： EXPERT REVIEW OF VACCINES, 2021; 20 (7)
Background: Since 2016, China has approved the use of inactivated enterovirus 71 (EV71) vaccines produced by three manufacturers. The coverage and saf......
期刊： EXPERT REVIEW OF VACCINES, 2021; 20 (5)
Introduction Cancer remains a major source of disease burden worldwide. Although cancer vaccines have been developed, most currently available cancer ......
期刊： EXPERT REVIEW OF VACCINES, 2021; 20 (4)
Introduction: As the global severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic continues to spread, several variants have emerged. ......
期刊： EXPERT REVIEW OF VACCINES, 2021; 20 (7)
Introduction: Adjuvants are essential to vaccines for immunopotentiation in the elicitation of protective immunity. However, classical and widely used......
期刊： EXPERT REVIEW OF VACCINES, 2021; 20 (5)
Background: Our study aims to explore the epidemiological features of children with bacterial culture-confirmed pertussis visiting Beijing Children's ......
期刊： EXPERT REVIEW OF VACCINES, 2021; 20 (7)
Objectives: China has implemented universal hepatitis B vaccination since 2002 and provided charge-free hepatitis B immunoglobulin (HBIG) to infants o......
期刊： EXPERT REVIEW OF VACCINES, 2021; 20 (4)
Introduction: Coronavirus Disease 2019 (COVID-19) poses a substantial threat to the lives of the elderly, especially those with neurodegenerative dise......
期刊： EXPERT REVIEW OF VACCINES, 2021; 20 (7)
Introduction: The coronavirus disease 2019 (COVID-19) pandemic continues to spread worldwide and vaccination remains the most effective approach to co......
期刊： EXPERT REVIEW OF VACCINES, 2021; 20 (9)
Background It remains hesitant to include a two-dose varicella vaccine (VarV) in a national routine immunization program in China. We aimed to quantif......
